154 related articles for article (PubMed ID: 35912230)
1. ZFAND5 Is an Independent Prognostic Biomarker of Perihilar Cholangiocarcinoma.
Liu P; Wang Y; Duan L
Front Oncol; 2022; 12():955670. PubMed ID: 35912230
[TBL] [Abstract][Full Text] [Related]
2. Dual-Specificity Phosphatase 11 Is a Prognostic Biomarker of Intrahepatic Cholangiocarcinoma.
Xu L; Wang P; Zhang W; Li W; Liu T; Che X
Front Oncol; 2021; 11():757498. PubMed ID: 34660327
[TBL] [Abstract][Full Text] [Related]
3. The expression, clinical relevance, and prognostic significance of HJURP in cholangiocarcinoma.
Yang Y; Yuan J; Liu Z; Cao W; Liu P
Front Oncol; 2022; 12():972550. PubMed ID: 35965590
[TBL] [Abstract][Full Text] [Related]
4. The Smad4-MYO18A-PP1A complex regulates β-catenin phosphorylation and pemigatinib resistance by inhibiting PAK1 in cholangiocarcinoma.
Liu J; Ren G; Li K; Liu Z; Wang Y; Chen T; Mu W; Yang X; Li X; Shi A; Zhao W; Xu B; Chang J; Guo S; Pan C; Zhou T; Zhang Z; Xu Y
Cell Death Differ; 2022 Apr; 29(4):818-831. PubMed ID: 34799729
[TBL] [Abstract][Full Text] [Related]
5. Targeted Therapies for Perihilar Cholangiocarcinoma.
Gray S; Lamarca A; Edeline J; Klümpen HJ; Hubner RA; McNamara MG; Valle JW
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406560
[TBL] [Abstract][Full Text] [Related]
6. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
[TBL] [Abstract][Full Text] [Related]
7. HMGA1-TRIP13 axis promotes stemness and epithelial mesenchymal transition of perihilar cholangiocarcinoma in a positive feedback loop dependent on c-Myc.
Li Z; Liu J; Chen T; Sun R; Liu Z; Qiu B; Xu Y; Zhang Z
J Exp Clin Cancer Res; 2021 Mar; 40(1):86. PubMed ID: 33648560
[TBL] [Abstract][Full Text] [Related]
8. KLF4 suppresses the proliferation of perihilar cholangiocarcinoma by negatively regulating GDF15 and phosphorylating AKT.
Zhang X; Wang W; Lu C; Zhang H
Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37937607
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for perihilar cholangiocarcinoma: a hospital-based case-control study.
Lee BS; Cha BH; Park EC; Roh J
Liver Int; 2015 Mar; 35(3):1048-53. PubMed ID: 24923595
[TBL] [Abstract][Full Text] [Related]
10. Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinoma.
Zheng Y; Qin Y; Gong W; Li H; Li B; Wang Y; Chao B; Zhao S; Liu L; Yao S; Shi J; Shi X; Wang K; Xu S
J Gastrointest Oncol; 2021 Dec; 12(6):2631-2642. PubMed ID: 35070393
[TBL] [Abstract][Full Text] [Related]
11. Cholangiocarcinoma miscoding in hepatobiliary centres.
Selvadurai S; Mann K; Mithra S; Bridgewater J; Malik H; Khan SA
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):635-639. PubMed ID: 33032867
[TBL] [Abstract][Full Text] [Related]
12. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
Izquierdo-Sanchez L; Lamarca A; La Casta A; Buettner S; Utpatel K; Klümpen HJ; Adeva J; Vogel A; Lleo A; Fabris L; Ponz-Sarvise M; Brustia R; Cardinale V; Braconi C; Vidili G; Jamieson NB; Macias RI; Jonas JP; Marzioni M; Hołówko W; Folseraas T; Kupčinskas J; Sparchez Z; Krawczyk M; Krupa Ł; Scripcariu V; Grazi GL; Landa-Magdalena A; Ijzermans JN; Evert K; Erdmann JI; López-López F; Saborowski A; Scheiter A; Santos-Laso A; Carpino G; Andersen JB; Marin JJ; Alvaro D; Bujanda L; Forner A; Valle JW; Koerkamp BG; Banales JM
J Hepatol; 2022 May; 76(5):1109-1121. PubMed ID: 35167909
[TBL] [Abstract][Full Text] [Related]
13. The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers.
Zhang Y; Ma Z; Li C; Wang C; Jiang W; Chang J; Han S; Lu Z; Shao Z; Wang Y; Wang H; Jiao C; Wang D; Wu X; Shen H; Wang X; Hu Z; Li X
Nat Commun; 2022 Jun; 13(1):3061. PubMed ID: 35650238
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-33 overexpression reflects less aggressive tumour features in large-duct type cholangiocarcinomas.
Sawada R; Ku Y; Akita M; Otani K; Fujikura K; Itoh T; Ajiki T; Fukumoto T; Kakeji Y; Zen Y
Histopathology; 2018 Aug; 73(2):259-272. PubMed ID: 29675965
[TBL] [Abstract][Full Text] [Related]
15. Development of a model based on the age-adjusted Charlson comorbidity index to predict survival for resected perihilar cholangiocarcinoma.
Pan Y; Liu ZP; Dai HS; Chen WY; Luo Y; Wang YZ; Gao SY; Wang ZR; Dong JL; Liu YH; Yin XY; Liu XC; Fan HN; Bai J; Jiang Y; Cheng JJ; Zhang YQ; Chen ZY
World J Gastrointest Oncol; 2023 Jun; 15(6):1036-1050. PubMed ID: 37389112
[TBL] [Abstract][Full Text] [Related]
16. Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodies.
Kriegsmann M; Roessler S; Kriegsmann K; Renner M; Longuespée R; Albrecht T; Loeffler M; Singer S; Mehrabi A; Vogel MN; Pathil A; Köhler B; Springfeld C; Rupp C; Weiss KH; Goeppert B
BMC Cancer; 2019 Jan; 19(1):72. PubMed ID: 30646854
[TBL] [Abstract][Full Text] [Related]
17. Comparison of clinical characteristics and mortality risk between patients with cholangiocarcinoma: A retrospective cohort study.
Liu Y; Wang Y; Yu Y; Luo H; Zhen M; Ren J
Front Surg; 2022; 9():1037310. PubMed ID: 36873806
[TBL] [Abstract][Full Text] [Related]
18. Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.
Chen P; Li B; Zhu Y; Chen W; Liu X; Li M; Duan X; Yi B; Wang J; Liu C; Luo X; Li X; Li J; Liang L; Yin X; Wang H; Jiang X
Oncotarget; 2016 Jun; 7(24):37319-37330. PubMed ID: 27144432
[TBL] [Abstract][Full Text] [Related]
19. Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma.
Geers J; Jaekers J; Topal H; Aerts R; Vandoren C; Vanden Boer G; Topal B
World J Surg Oncol; 2020 Nov; 18(1):286. PubMed ID: 33143698
[TBL] [Abstract][Full Text] [Related]
20. Significance of HMGA2 expression as independent poor prognostic marker in perihilar and distal cholangiocarcinoma resected with curative intent.
Takahashi T; Kawaji H; Murakawa Y; Hayashizaki Y; Murakami T; Yabushita Y; Homma Y; Kumamoto T; Matsuyama R; Endo I
Eur J Surg Oncol; 2021 Feb; 47(2):394-400. PubMed ID: 32878723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
